Taken together, these results reveal that Lnc-LSG1 promotes ccRCC metastasis by directly binding to the ESRP2 protein, thus inhibiting its expression through the ubiquitin-proteasome pathway. This evidence concerns the gene ESRP2 and nonpapillary renal cell carcinoma.